(Q55052506)

16 June 2018

title

TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. (English)

1 reference

16 June 2018

main subject

TNF

0 references

mesenchymal stem cell

1 reference

2

1 reference

16 June 2018

Giorgio Zauli

8

1 reference

16 June 2018

Antonio Paolo Beltrami

object named as

Antonio Paolo Beltrami

3

0 references

Federica Corallini

1

object named as

Federica Corallini

1 reference

16 June 2018

author name string

Daniela Cesselli

4

1 reference

16 June 2018

Elisa Puppato

5

1 reference

16 June 2018

Roberto Ferrari

6

1 reference

16 June 2018

Carlo Alberto Beltrami

7

1 reference

16 June 2018

publication date

9 January 2010

1 reference

16 June 2018

Cellular and Molecular Life Sciences

published in

1 reference

16 June 2018

volume

67

1 reference

16 June 2018

issue

8

1 reference

16 June 2018

page(s)

1307-1314

1 reference

16 June 2018

https://scigraph.springernature.com/pub.10.1007/s00018-009-0246-5

exact match

0 references

cites work

Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology

1 reference

12 December 2020

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure

1 reference

12 December 2020

The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice

1 reference

12 December 2020

An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction

1 reference

12 December 2020

Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction

1 reference

12 December 2020

MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines.

1 reference

12 December 2020

Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

1 reference

12 December 2020

Soluble TRAIL prevents RANTES-dependent restenosis after percutaneous coronary intervention in patients with coronary artery disease

1 reference

12 December 2020

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart

1 reference

12 December 2020

Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction

1 reference

12 December 2020

Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone

1 reference

12 December 2020

Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes

1 reference

12 December 2020

Increased osteoprotegerin serum levels in men with coronary artery disease

1 reference

12 December 2020

TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium.

1 reference

12 December 2020

TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells

1 reference

12 December 2020

Increased circulating concentrations and augmented myocardial extraction of osteoprotegerin in heart failure due to left ventricular pressure overload

1 reference

12 December 2020

Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease

1 reference

12 December 2020

Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.

1 reference

12 December 2020

The role of tumor necrosis factor in the pathophysiology of heart failure

1 reference

12 December 2020

The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review

1 reference

12 December 2020

Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro.

1 reference

12 December 2020

The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities

1 reference

12 December 2020

Role of full-length osteoprotegerin in tumor cell biology

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells

1 reference

12 December 2020

Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells

1 reference

12 December 2020

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells.

1 reference

12 December 2020

Stem cell engineering for treatment of heart diseases: potentials and challenges

1 reference

12 December 2020

Excessive Tumor Necrosis Factor Activation After Infarction Contributes to Susceptibility of Myocardial Rupture and Left Ventricular Dysfunction

1 reference

12 December 2020

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

1 reference

12 December 2020

Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).

1 reference

12 December 2020

Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells

1 reference

12 December 2020

Improvement in cardiac function after bone marrow cell thearpy is associated with an increase in myocardial inflammation.

1 reference

12 December 2020

Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction

1 reference

12 December 2020

TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release

1 reference

12 December 2020

Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction

1 reference

12 December 2020

Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction

1 reference

12 December 2020

Systemic Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery Shows Antiatherosclerotic Activity in Apolipoprotein E–Null Diabetic Mice

1 reference

12 December 2020

Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction

1 reference

12 December 2020

Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes

1 reference

12 December 2020

Prognostic value of apoptosis markers in advanced heart failure patients.

1 reference

12 December 2020

10.1007/S00018-009-0246-5

Identifiers

DOI

1 reference

16 June 2018

Dimensions Publication ID

1013285099

0 references

1 reference

16 June 2018